Detalles de la búsqueda
1.
Trends in uterine cancer incidence in the United States: The contribution of age, period and cohort effects.
Gynecol Oncol
; 187: 151-162, 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38781746
2.
Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium.
Br J Cancer
; 129(12): 1956-1967, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37865688
3.
Model-Projected Cost-Effectiveness of Adult Hearing Screening in the USA.
J Gen Intern Med
; 38(4): 978-985, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35931909
4.
Maternal morbidity and mortality among patients with cancer at time of delivery.
Am J Obstet Gynecol
; 229(3): 324.e1-324.e7, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37295633
5.
Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
Am J Obstet Gynecol
; 229(3): 275.e1-275.e17, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244458
6.
Geographic variation in the rate and route of hysterectomy for benign disease in the USA: A retrospective cross-sectional study.
BJOG
; 130(12): 1502-1510, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37132056
7.
Cost-effectiveness of agents used for evaluation of ureteral patency during intraoperative cystoscopy in gynecologic and urogynecologic surgery.
Am J Obstet Gynecol
; 226(1): 100.e1-100.e6, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34487702
8.
Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis.
Am J Obstet Gynecol
; 225(5): 513.e1-513.e19, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34058170
9.
Protocol for implementation of an evidence based parentally administered intervention for preterm infants.
BMC Pediatr
; 21(1): 142, 2021 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33761902
10.
Cost-effectiveness analysis comparing "PARP inhibitors-for-all" to the biomarker-directed use of PARP inhibitor maintenance therapy for newly diagnosed advanced stage ovarian cancer.
Gynecol Oncol
; 159(2): 483-490, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32863036
11.
Addressing heterogenous outcomes in uterine fibroid research: a call to action.
Am J Obstet Gynecol
; 223(1): 75.e1-75.e5, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32199924
12.
Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
Am J Obstet Gynecol
; 222(4): 345.e1-345.e22, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31678093
13.
Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach.
Genet Epidemiol
; 42(1): 117-122, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29193313
14.
Perspectives on the Costs of Cancer Care: A Survey of the American Society of Breast Surgeons.
Ann Surg Oncol
; 26(10): 3141-3151, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31342390
15.
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
CA Cancer J Clin
; 62(3): 147-72, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22422631
16.
Simulation model of the relationship between cesarean section rates and labor duration.
Health Care Manag Sci
; 22(4): 635-657, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29995263
17.
Induction of Labor versus Scheduled Cesarean in Morbidly Obese Women: A Cost-Effectiveness Analysis.
Am J Perinatol
; 36(4): 399-405, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30130822
18.
The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Am J Obstet Gynecol
; 219(1): 95.e1-95.e10, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29750955
19.
Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.
Ann Surg Oncol
; 24(11): 3116-3123, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28699130
20.
Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers.
Gynecol Oncol
; 145(3): 549-554, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28390820